32 results
Thumbnail

D2.44 - Subjective assessment of sleep quality in adult patients with hereditary angioedema

Thumbnail

D2.47 - Unmasking Melkersson-Rosenthal Syndrome: Diagnostic Challenges in a Patinent Pressenting With Angioedema

Thumbnail

D2.57 - Evidence of Lower Airway Inflammation in Children with Allergic Rhinitis without Asthma

Thumbnail

D2.43 - Hereditary Angioedema Can Hit at Any Age: A Case Report in Egypt

Thumbnail

D2.45 - Fixed Drug Eruption Due to Fenofibrate Hypersensitivity

Thumbnail

D2.46 - Patient with the overlap of Hereditary angioedema and Chronic spontaneous urticaria

Thumbnail

D2.48 - When Treatment Becomes the Cause: Allergic Contact Dermatitis to Topical Corticosteroids

Thumbnail

D2.49 - Quality of Life and Affecting Factors in Patients with Chronic Urticaria

Thumbnail

D2.50 - When Angioedema Is Not Angioedema: Orofacial Sarcoidosis Mimicking Refractory Facial Swelling

Thumbnail

D2.51 - Contact dermatitis due to continuous glucose monitoring sensors: limitations of standard patch testing

Thumbnail

D2.53 - Impact of Smoking on the Clinical and Allergological Profile of Allergic Contact Dermatitis: An 8-Year Analytical Study

Thumbnail

D2.54 - Correlation Between IgE Anti-Thyroid Peroxidase And Chronic Spontaneous Urticaria

Thumbnail

D2.55 - Allergic contact dermatitis and cross-sensitization after laser-assisted 5-aminolevulinic acid PDT

Thumbnail

D2.56 - Regionally Adapted Patch Test Panels Improve Diagnostic Resolution by Revealing Hidden Polysensitization in Allergic Contact Dermatitis

Thumbnail

D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.423 - Lanadelumab treatment is effective and safe in patients with Factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study